These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 904673)

  • 1. Skin reaction to systemic 5-FU -- a therapeutic bonus.
    Omura EF
    N Engl J Med; 1977 Oct; 297(17):946. PubMed ID: 904673
    [No Abstract]   [Full Text] [Related]  

  • 2. Pustular contact hypersensitivity to fluorouracil with rosacealike sequelae.
    Sevadjian CM
    Arch Dermatol; 1985 Feb; 121(2):240-2. PubMed ID: 3977340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed hypersensitivity to 5-fluorouracil following topical chemotherapy of cutaneous cancers.
    Mansell PW; Litwin MS; Ichinose H; Krementz ET
    Cancer Res; 1975 May; 35(5):1288-94. PubMed ID: 1120313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute angioedema response to topical 5-fluorouracil therapy.
    Maughan C; Lear W
    Dermatol Online J; 2013 Mar; 19(3):13. PubMed ID: 23552010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin reactions to 5-fluorouracil.
    Bernstein T
    N Engl J Med; 1977 Aug; 297(6):337-8. PubMed ID: 141618
    [No Abstract]   [Full Text] [Related]  

  • 6. Painful scrotal dermatitis secondary to topical 5-fluorouracil.
    Yi JZ; Himes RS; Smith RJ; McKee PH; Roberts AA
    Dermatol Online J; 2021 Jun; 27(6):. PubMed ID: 34387061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethogel topical formulation for increasing the local bioavailability of 5-fluorouracil: a mechanistic study.
    Puri R; Jain S
    Anticancer Drugs; 2012 Oct; 23(9):923-34. PubMed ID: 22926258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Attention: the modification of the pH of 5-fluorouracil (5-FU) makes it inappropriate for subconjunctival injection].
    Malek-Chéhire N; Legeais JM; Renard G; Pouliquen Y
    J Fr Ophtalmol; 1994; 17(11):683. PubMed ID: 7722229
    [No Abstract]   [Full Text] [Related]  

  • 9. Local erythema multiforme-like drug reaction following intravenous mitomycin C and 5-fluorouracil.
    Spencer HJ
    J Surg Oncol; 1984 May; 26(1):47-50. PubMed ID: 6328125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Toxicity of 5-FU].
    Béchetoille A
    J Fr Ophtalmol; 1995; 18(3):230. PubMed ID: 7759763
    [No Abstract]   [Full Text] [Related]  

  • 11. Intralesional 5-fluorouracil in keloid treatment: a systematic review.
    Bijlard E; Steltenpool S; Niessen FB
    Acta Derm Venereol; 2015 Sep; 95(7):778-82. PubMed ID: 25805099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does intermittent "pulse" topical 5-fluorouracil therapy allow destruction of actinic keratoses without significant inflammation?
    Epstein E
    J Am Acad Dermatol; 1998 Jan; 38(1):77-80. PubMed ID: 9448209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical fluorouracil therapy for precancers and cancers of the skin.
    Cullen SI
    J Am Geriatr Soc; 1979 Dec; 27(12):529-35. PubMed ID: 159921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe systemic effects with topical fluorouracil.
    Prescrire Int; 2001 Dec; 10(56):184. PubMed ID: 11824445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term topical 5-FU therapy: report of two cases.
    Ryan RF
    J La State Med Soc; 1978 Mar; 130(3):61-3. PubMed ID: 76666
    [No Abstract]   [Full Text] [Related]  

  • 16. Fatal immune haemolysis due to antibodies to individual metabolites of 5-fluorouracil.
    Yürek S; Riess H; Kreher S; Dörken B; Salama A
    Transfus Med; 2010 Aug; 20(4):265-8. PubMed ID: 20456688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease.
    Salim A; Leman JA; McColl JH; Chapman R; Morton CA
    Br J Dermatol; 2003 Mar; 148(3):539-43. PubMed ID: 12653747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity of 5-fluorouracil.
    Macdonald JS
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):33-4. PubMed ID: 10442356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, Safety, and Tolerability of 4% 5-Fluorouracil Cream in a Novel Patented Aqueous Cream Containing Peanut Oil Once Daily Compared With 5% 5-Fluorouracil Cream Twice Daily: Meeting the Challenge in the Treatment of Actinic Keratosis.
    Dohil MA
    J Drugs Dermatol; 2016 Oct; 15(10):1218-1224. PubMed ID: 27741339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorouracil is Superior to Other Commonly Used Topical Agents for the Treatment of Field Cancerization.
    Ouchene L; Litvinov IV; Netchiporouk E
    J Cutan Med Surg; 2019; 23(4):455-456. PubMed ID: 31337239
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.